Krebs in der Schwangerschaft: Reproduktionsmedizin und Fertilitätserhalt

Krebs in der Schwangerschaft (Gravidität, Grav) tritt derzeit bei etwa einer von 1000 Schwangerschaften auf. Da die Erfüllung eines Kinderwunsches heutzutage häufig erst mit Anfang 30 realisiert wird, liegt die Vermutung nahe, dass die Inzidenz der Grav-assoziierten Krebserkrankungen noch weiter ansteigen wird [1] [2]. Die Diagnose und Behandlung der Grav-assoziierten Krebserkrankung sind eine multidisziplinäre und ethische Herausforderung [3] [4].

Schlüsselwörter

Krebs - Schwangerschaft - Reproduktionsmedizin - Fertilitätserhalt - GnRHa - Eierstockgewebe - Oozyten - Eizellen

Publication History

Article published online:
28 November 2023

• Literatur

• 1 Silverstein J, Post AL, Chien AJ. et al. Multidisciplinary Management of Cancer During Pregnancy. JCO Oncol Pract 2020; 16: 545-557
• 2 Harwin J, Jha P, Post A. et al. The radiologist’s role in a multidisciplinary approach to cancer in pregnancy. Abdom Radiol 2023; 48: 1605-1611
• 3 Jha P, Pōder L, Glanc P. et al. Imaging Cancer in Pregnancy. Radiogr a Rev Publ Radiol Soc North Am Inc 2022; 42: 1494-1513
• 4 Galati F, Magri V, Arias-Cadena PA. et al. Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge. Diagnostics 2023; 13
• 5 Parazzini F, Gadducci A, Cicinelli E. et al. Pregnancy-associated cancers: frequency and temporal trends in Italy. Int J Gynecol cancer Off J Int Gynecol Cancer Soc 2020; 30: 241-244
• 6 Momen NC, Arendt LH, Ernst A. et al. Pregnancy-associated cancers and birth outcomes in children: a Danish and Swedish population-based register study. BMJ Open 2018; 8: e022946
• 7 Safi N, Li Z, Anazodo A. et al. Pregnancy associated cancer, timing of birth and clinical decision making-a NSW data linkage study. BMC Pregnancy Childbirth 2023; 23: 105
• 8 Dittrich R, Kliesch S, Schüring A. et al. Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women. Geburtshilfe Frauenheilkd 2018; 78: 567-584
• 9 ASRM. E committee of the. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril 2013; 100: 1224-1231
• 10 Beckmann MW, Dittrich R, Findeklee S. et al. Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation. Geburtshilfe Frauenheilkd 2016; 76: 1057-1064
• 11 Henry L, Labied S, Jouan C. et al. Preservation of female fertility: The current therapeutic strategy. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet 2022; 156: 3-9
• 12 Pereira N, Kligman I, Hunt R. et al. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer. Gynecol Endocrinol 2019; 35: 214-216
• 13 Ben-Haroush A, Abir R, Sapir O. et al. Aspiration of immature oocytes during cesarean section for fertility preservation. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 2017; 30: 2112-2114
• 14 Ben-Haroush A, Sapir O, Fisch B. Aspiration of immature oocytes during cesarean section for fertility preservation and future surrogacy. Am J Obstet Gynecol 2010; 203: e12-4
• 15 DIR Jahrbuch 2021. J für Reproduktionsmedizin und Endokrinol; Special ed. 2022
• 16 Casswell G, Gough K, Drosdowsky A. et al. Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study. Int J Radiat Oncol Biol Phys 2021; 110: 382-393
• 17 Eaker S, Wigertz A, Lambert PC. et al. Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS One 2011; 6: e18040
• 18 Danis RB, Pereira N, Elias RT. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Curr Pharm Biotechnol 2017; 18: 609-613
• 19 Goldman RH, Racowsky C, Farland LV. et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod 2017; 32: 853-859
• 20 Cobo A, García-Velasco JA, Remohí J. et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril 2021; 115: 1091-1101
• 21 Ruan X. Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy. Gynecol Endocrinol 2022; 38: 797-802
• 22 Winship AL, Stringer JM, Liew SH. et al. The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing. Hum Reprod Update 2018; 24: 119-134
• 23 Vo KCT, Kawamura K. Female Oncofertility: Current Understandings, Therapeutic Approaches, Controversies, and Future Perspectives. J Clin Med 2021; 10
• 24 DIR Jahrbuch 2019. 2020 https://www.deutsches-ivf-register.de/perch/resources/dir-jahrbuch-2019-de.pdf
• 25 Beckmann MW, Dittrich R, Lotz L. et al. Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue. Reprod Biomed Online 2018; 36: 188-196
• 26 Mayerhofer K, Ott J, Nouri K. et al. Laparoscopic ovarian tissue harvesting for cryopreservation: an effective and safe procedure for fertility preservation. Eur J Obstet Gynecol Reprod Biol 2010; 152: 68-72
• 27 Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2019; 112: 1022-1033
• 28 Cheng J, Ruan X, Du J. et al. Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report. J Ovarian Res 2021; 14: 1-7
• 29 De Vos M, Grynberg M, Ho TM. et al. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet 2021; 38: 1265-1280
• 30 Karimi-Zarchi M, Khalili MA, Binesh F. et al. Ovarian Tissue Reservation and Risk of Reimplantation in a Young Girl with Acute Lymphocytic Leukemia after 6-Month Chemotherapy: A Case Report. South Asian J cancer 2021; 10: 112-114
• 31 Poirot C, Fortin A, Dhédin N. et al. Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies. Haematologica 2019; 104: e360-e363
• 32 Rosen MA. Management of anesthesia for the pregnant surgical patient. Anesthesiology 1999; 91: 1159-1163
• 33 Pennington TB, Stein SJ. Carbon dioxide for obstetric pneumoperitoneum. Anesthesiology 2000; 93: 270-271
• 34 Ball E, Waters N, Cooper N. et al. Correction: Evidence-Based Guideline on Laparoscopy in Pregnancy: Commissioned by the British Society for Gynaecological Endoscopy (BSGE) Endorsed by the Royal College of Obstetricians & Gynaecologists (RCOG). Facts, views Vis ObGyn 2020; 11: 261
• 35 Silvestri MT, Pettker CM, Brousseau EC. et al. Morbidity of appendectomy and cholecystectomy in pregnant and nonpregnant women. Obstet Gynecol 2011; 118: 1261-1270
• 36 Balinskaite V, Bottle A, Sodhi V. et al. The Risk of Adverse Pregnancy Outcomes Following Nonobstetric Surgery During Pregnancy: Estimates From a Retrospective Cohort Study of 6.5 Million Pregnancies. Ann Surg 2017; 266: 260-266
• 37 Kuczkowski KM. The safety of anaesthetics in pregnant women. Expert Opin Drug Saf 2006; 5: 251-264
• 38 Okeagu CN, Anandi P, Gennuso S. et al. Clinical management of the pregnant patient undergoing non-obstetric surgery: Review of guidelines. Best Pract Res Clin Anaesthesiol 2020; 34: 269-281
• 39 Oktay K, Harvey BE, Partridge AH. et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol Off J Am Soc Clin Oncol 2018; 36: 1994-2001
• 40 Arecco L, Perachino M, Damassi A. et al. Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients. Breast Cancer (Auckl) 2020; 14: 1178223420954179
• 41 Valsamakis G, Valtetsiotis K, Charmandari E. et al. GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation. Int J Mol Sci 2022; 23
• 42 Munhoz RR, Pereira AAL, Sasse AD. et al. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016; 2: 65-73
• 43 Costa-Roig A, Andrés Moreno M, Bordallo Vázquez M. et al. Ovarian transposition as a minimally invasive fertility preservation technique: ten years of experience in a pediatric center. Cir Pediatr 2020; 33: 25-29
• 44 Garg D, Johnstone EB, Lomo L. et al. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. J Assist Reprod Genet 2020; 37: 1467-1476
• 45 Steigrad S, Hacker NF, Kolb B. In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy. Fertil Steril 2005; 83: 1547-1549
• 46 Michalet M, Dejean C, Schick U. et al. Radiotherapy and pregnancy. Cancer Radiother J la Soc Fr Radiother Oncol 2022; 26: 417-423
• 47 Buonomo B, Brunello A, Noli S. et al. Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases. Breast Care (Basel) 2020; 15: 148-156
• 48 Iguchi T, Hirokawa M, Takasugi N. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology 1986; 42: 1-11
• 49 Pagani O, Partridge AH, Peccatori F. et al. Abstract OT1–01–06: POSITIVE: A study evaluating Pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsIVE breast cancer who desire pregnancy (IBCSG 48–14/BIG 8–13). Cancer Res 2019; 79: OT1–01–06